======= C1orf109 ======= == Gene Information == * **Official Symbol**: C1orf109 * **Official Name**: chromosome 1 open reading frame 109 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54955|54955]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NX04|Q9NX04]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C1orf109&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C1orf109|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May promote cancer cell proliferation by controlling the G1 to S phase transition. {ECO:0000269|PubMed:22548824}. No Pfam Domain information is available for this gene. No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp280|Daidzin 10μM R06 exp280]]|-2.1| |[[:results:exp100|NFN1 1μM R03 exp100]]|-2.09| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 738/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|26/26| |breast|33/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|74/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 892 * **Expression level (log2 read counts)**: 5.15 {{:chemogenomics:nalm6 dist.png?nolink |}}